Luyan Pharma Co.,Ltd.

002788

CNE1000025W1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
8.13 ^CNY	+3.57%		-7.09%	-9.57%

08/05	Luyan Pharma Co.,Ltd. Approves Cash Dividend for the Year 2023	CI
15/04	Luyan Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Luyan Pharma Co.,Ltd. Announces Profit Distribution Proposal for 2020

April 29, 2021 at 01:23 am IST

Luyan Pharma Co.,Ltd. announced profit distribution proposal for 2020 a cash dividend per 10 shares CNY 2.00000000 (tax included).

Latest news about Luyan Pharma Co.,Ltd.

Luyan Pharma Co.,Ltd. Approves Cash Dividend for the Year 2023	08/05	CI
Luyan Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/04	CI
Luyan Pharma Co.,Ltd. Announces Board Appointments	02/11	CI
Luyan Pharma Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23/23/23	CI
Hainan Luyan Pharma Co., Ltd. announced that it expects to receive CNY 58.5 million in funding from Luyan Pharma Co.,Ltd.	11/23/11	CI
Luyan Pharma Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	07/23/07	CI
Luyan Pharma Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 14, 2023	08/23/08	CI
Luyan Pharma Co.,Ltd. Approves Cash Dividend for 2022	11/23/11	CI
Luyan Pharma Co.,Ltd. Proposes Final Dividend for 2022	19/23/19	CI
Luyan Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/23/17	CI
Luyan Pharma Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/23/17	CI
Luyan Pharma Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/22/24	CI
Luyan Pharma Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22/22/22	CI
Luyan Pharma Co.,Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payable on 06 July 2022	30/22/30	CI
Luyan Pharma Co.,Ltd. Announces Cash Dividend for the Year 2021	19/22/19	CI
Luyan Pharma Co.,Ltd. Proposes Final Cash Dividend for the Year 2021	27/22/27	CI
Luyan Pharma Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25	CI
Luyan Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	25/22/25	CI
Luyan Pharma Co.,Ltd. completed the acquisition Luyan Group from Xiamen Maidiken Science & Technology Co., Ltd.	29/21/29	CI
Luyan Pharma Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/21/28	CI
Zhangzhou Luyan Pharmaceutical Co., Ltd announced that it expects to receive CNY 85 million in funding from Luyan Pharma Co.,Ltd.	27/21/27	CI
Nanping Luyan Pharmaceutical Co., Ltd. announced that it expects to receive CNY 38 million in funding from Luyan Pharma Co.,Ltd.	27/21/27	CI
Quanzhou Luyan Pharmaceutical Co., Ltd. announced that it expects to receive CNY 89.2 million in funding from Luyan Pharma Co.,Ltd.	27/21/27	CI
Fuzhou Luyan Pharmaceutical Co., Ltd. announced that it expects to receive CNY 69.92 million in funding from Luyan Pharma Co.,Ltd.	27/21/27	CI
Sanming Luyan Pharmaceutical Co., Ltd. announced that it expects to receive CNY 25 million in funding from Luyan Pharma Co.,Ltd.	27/21/27	CI

Luyan Pharma Co., Ltd., formerly LUYAN (FUJIAN) PHARMA CO., LTD. is principally engaged in the distribution and pharmaceutical retail chain business of medicine, Chinese herbal medicine, medical instrument and the second type vaccine. The Company makes Fujian Province as its major target market and provides its products directly to medical institutions at all levels.

Sector

Pharmaceuticals

Calendar

20/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
LUYAN PHARMA CO.,LTD.	-9.57%	44Cr
MCKESSON CORPORATION	+26.77%	7.63TCr
CARDINAL HEALTH, INC.	-2.27%	2.4TCr
SINOPHARM GROUP CO. LTD.	+10.27%	900.83Cr
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+12.25%	866.97Cr
HUADONG MEDICINE CO., LTD	-24.34%	757.62Cr
H. LUNDBECK A/S	+13.00%	517.56Cr
GALENICA AG	+2.34%	416.19Cr
EBOS GROUP LIMITED	-4.96%	398.33Cr
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-1.36%	363.3Cr

Pharmaceuticals Wholesale